103 related articles for article (PubMed ID: 21184183)
21. Are we going to close social gaps in HIV? Likely effects of behavioral HIV-prevention interventions on health disparities.
Albarracin D; Durantini MR
Psychol Health Med; 2010 Dec; 15(6):694-719. PubMed ID: 21154022
[TBL] [Abstract][Full Text] [Related]
22. Operational research to improve HIV prevention in the United States.
Herbst JH; Glassman M; Carey JW; Painter TM; Gelaude DJ; Fasula AM; Raiford JL; Freeman AE; Harshbarger C; Viall AH; Purcell DW
J Acquir Immune Defic Syndr; 2012 Apr; 59(5):530-6. PubMed ID: 22217681
[TBL] [Abstract][Full Text] [Related]
23. Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach.
McNaghten AD; Wolfe MI; Onorato I; Nakashima AK; Valdiserri RO; Mokotoff E; Romaguera RA; Kroliczak A; Janssen RS; Sullivan PS
PLoS One; 2007 Jun; 2(6):e550. PubMed ID: 17579722
[TBL] [Abstract][Full Text] [Related]
24. Estimating the epidemic consequences of HIV prevention gaps among key populations.
Mishra S; Silhol R; Knight J; Phaswana-Mafuya R; Diouf D; Wang L; Schwartz S; Boily MC; Baral S
J Int AIDS Soc; 2021 Jul; 24 Suppl 3(Suppl 3):e25739. PubMed ID: 34189863
[TBL] [Abstract][Full Text] [Related]
25. Behavioral and social interventions to promote optimal HIV prevention and care continua outcomes in the United States.
Gamarel KE; King WM; Operario D
Curr Opin HIV AIDS; 2022 Mar; 17(2):65-71. PubMed ID: 35067595
[TBL] [Abstract][Full Text] [Related]
26. Sharing Results From the Field - Tracking and Monitoring Clinical Measures: Examples of Practice-Based Evidence from Recipients of CDC's Heart Disease and Stroke Prevention Funding.
Patanian M
J Public Health Manag Pract; 2024 Jul-Aug 01; 30():S15-S17. PubMed ID: 38870355
[No Abstract] [Full Text] [Related]
27. Update on the Epidemiology and Prevention of HIV/AIDS in the United States.
Castel AD; Magnus M; Greenberg AE
Curr Epidemiol Rep; 2015 Jun; 2(2):110-119. PubMed ID: 25960941
[TBL] [Abstract][Full Text] [Related]
28. Mathematical models for HIV transmission dynamics: tools for social and behavioral science research.
Cassels S; Clark SJ; Morris M
J Acquir Immune Defic Syndr; 2008 Mar; 47 Suppl 1(Suppl 1):S34-9. PubMed ID: 18301132
[TBL] [Abstract][Full Text] [Related]
29. Cancer Prevention During Early Adulthood: Highlights From a Meeting of Experts.
Holman DM; White MC; Shoemaker ML; Massetti GM; Puckett MC; Brindis CD;
Am J Prev Med; 2017 Sep; 53(3S1):S5-S13. PubMed ID: 28818246
[TBL] [Abstract][Full Text] [Related]
30. Conceptual Frameworks in Scientific Inquiry and the Centers for Disease Control and Prevention's Approach to Pesticide Toxicity (1948-1968).
Washburn R
Am J Public Health; 2019 Nov; 109(11):1548-1556. PubMed ID: 31577488
[TBL] [Abstract][Full Text] [Related]
31. Africa CDC's viral hepatitis prevention and control programme: a continental initiative to support elimination programmes.
Tesfahunei HA; Abdulaziz M; Chotun N; Ward JW; Hassany M; Kaseya J
Lancet Gastroenterol Hepatol; 2024 Apr; 9(4):284-286. PubMed ID: 38367626
[No Abstract] [Full Text] [Related]
32. Evaluation of emergency drug releases from the Centers for Disease Control and Prevention Quarantine Stations.
Roohi S; Grinnell M; Sandoval M; Cohen NJ; Crocker K; Allen C; Dougherty C; Jolly J; Pesik N
J Emerg Manag; 2015; 13(1):19-23. PubMed ID: 25779896
[TBL] [Abstract][Full Text] [Related]
33. Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics.
Joshi K; Rumpler E; Kennedy-Shaffer L; Bosan R; Lipsitch M
medRxiv; 2022 Jul; ():. PubMed ID: 34212161
[TBL] [Abstract][Full Text] [Related]
34. CDC's Revised Developmental Milestone Checklists.
Zubler J; Whitaker T
Am Fam Physician; 2022 Oct; 106(4):370-371. PubMed ID: 36260888
[No Abstract] [Full Text] [Related]
35. Network-level pavement maintenance and rehabilitation decision-making with the optimized annual budget.
Chen L
PLoS One; 2023; 18(10):e0287426. PubMed ID: 37883363
[TBL] [Abstract][Full Text] [Related]
36. HIV Transmission Rates in the United States, 2006-2008.
Holtgrave DR; Hall HI; Prejean J
Open AIDS J; 2012; 6():26-8. PubMed ID: 22496716
[TBL] [Abstract][Full Text] [Related]
37. Efficient Risk Mitigation Planning for a Clinical Trial.
Shnaydman V
Ther Innov Regul Sci; 2023 Jul; 57(4):717-727. PubMed ID: 37067681
[TBL] [Abstract][Full Text] [Related]
38. HIV: CHANGING SCENARIO AND NEW CHALLENGES.
Cherekar M
Med J Armed Forces India; 1999 Oct; 55(4):373. PubMed ID: 28790621
[No Abstract] [Full Text] [Related]
39. Optimal resource allocation in HIV self-testing secondary distribution among Chinese MSM: data-driven integer programming models.
Jing F; Zhang Q; Ong JJ; Xie Y; Ni Y; Cheng M; Huang S; Zhou Y; Tang W
Philos Trans A Math Phys Eng Sci; 2022 Jan; 380(2214):20210128. PubMed ID: 34802269
[TBL] [Abstract][Full Text] [Related]
40. Progression and transmission of HIV (PATH 4.0)-A new agent-based evolving network simulation for modeling HIV transmission clusters.
Singh S; France AM; Chen YH; Farnham PG; Oster AM; Gopalappa C
Math Biosci Eng; 2021 Mar; 18(3):2150-2181. PubMed ID: 33892539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
